Jump to content
RemedySpot.com

Dougman, it looks like you are not right.

Rate this topic


Guest guest

Recommended Posts

Guest guest

GcMAF - treatment for cancer, aids and immune diseases

It is our immune system that prevents and cures cancer

A macrophage (purple) eats cancer cells

The first research was published in 1993 and since then many papers have

appeared indicating GcMAF rebuilds the immune system, and the immune system then

eradicated Cancer and HIV.

Dr. Nobuto Yamamoto in Philadelphia was the first, but hundreds of scientists

have now worked on this and related projects.

How does GcMAF work?

In a healthy person your GcMAF instructs macrophages in your bloodstream to

scour our bodies and kill malignancies. But malignant cells like cancer send out

an enzyme called Nagalase that neutralises your GcMAF; so the macrophages never

get the message to go into action – in this way cancer suppresses the immune

system, and cancer cells grow unchecked.

To reverse this, we make GcMAF outside the body, and it is injected once a week

for 25 weeks for early cancers, 50 or more weeks for late stage cancers.

(Encapsulated tumours require additional treatment.) HIV can require as little

as 16 weeks.

In its role of immune system regulator, research shows GcMAF can reverse other

diseases that attack the immune system like Osteoporosis, Aids, Hodgkin’s,

Lupus, MS, Fibromyalgia, Parkinson’s, various bacterial and viral infections

and various types of Immune dysfunction.

Small pre-clinical trials to build the case are again taking place.

Our GcMAF destroying human cancer cells for 72 hours. At 100ng/ml, panel D,

cells show an irregular shape and size. They are significantly smaller as if

processes of shrinkage had occurred. Cells appear inhomogeneous and both

cytoplasm and nucleus appear irregular as if fragmented. Numerous cellular

debris can be observed as well as apoptotic bodies. Clusters are much fewer in

number and their borders appear less defined.

Those diagnosed with any of these illnesses, and who have done their own

research on it, are invited to respond. We ask for a copy of diagnostic

information and update reports from a physician during and after treatments, to

help build the case that GcMAF is a cure for various illnesses, which will help

to make it available to the public. Participants are free to stop at any time.

What have we learned?

Dr Yamamoto carefully selected his trials: he took fit people with in the early

stages of cancer and HIV, and reported 100% success, with no recurrence after

many years. He did not attempt to cure people with large tumours.

Our trials are quite different: most people are over 50, some over 80, with

advanced or terminal cancers, with significant tumour mass.

We appear to have had stunning results in 20 percent of cases, and we think we

have learned enough to take that figure up to 50% in this 2011 round of trials.

GcMAF needs normal levels of vitamin D to function strongly, and those

participants can see significant tumour shrinkage in 8 weeks. But even in low

responders, GcMAF appears to stop the advance of cancer.

We have probably proved GcMAF can work for people up to age 90, with terminal

stage 4 cancer, and can completely destroy large tumour mass. See " Patients on

GcMAF " on the left.

Remember, GcMAF requires normal levels of vitamin D to work properly. So far

those patients who in 8 weeks are cured of symptoms, or whose tumour mass drops

significantly, all take 4000 IU plus of vitamin D, and outdoor exercise, perhaps

a 40 minute walk each day.

HIV participants who also take 4000IU plus of vitamin D daily can expect to see

nagalese drop to normal after 16 weeks.

But the beauty of using your own immune system to cure cancer is that it

remembers how to defeat it for the rest of your life: it doesn't come back. And

unlike chemotherapy, the side effects are trivial.

We are now beginning new preclinical trials, and have GcMAF available. See " Buy

GcMAF here, " top left. If you have questions, click " Contact " at the top to send

us an email, or call our contact person Noakes +44 752 844 1672.

Sent from my iPhone

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...